Ondřej Sedláček

Poly(2‐Oxazoline)s – Are They More Advantageous for Biomedical Applications Than Other Polymers?

Ondřej Sedláček, Bryn D. Monnery, Sergey K. Filippov et al. · Macromolecular Rapid Communications · 2012 · 301 citations

Drug Delivery Systems Based on Poly(2‐Oxazoline)s and Poly(2‐Oxazine)s

Ondřej Sedláček, Richard Hoogenboom · Advanced Therapeutics · 2019 · 129 citations · Full text

Hydrogels, Ethylene Glycol, Engineering +13

Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues

Ondřej Sedláček, Bryn D. Monnery, Jana Mattová et al. · Biomaterials · 2017 · 104 citations

Cancer Therapy, Medicinal Chemistry, Oncology +10

Defined High Molar Mass Poly(2‐Oxazoline)s

Bryn D. Monnery, Valentin Victor Jerca, Ondřej Sedláček et al. · Angewandte Chemie International Edition · 2018 · 80 citations · Full text

Engineering, Responsive Polymers, Oxazolinium Chain End +18

A simple neridronate-based surface coating strategy for upconversion nanoparticles: highly colloidally stable¹²⁵I-radiolabeled NaYF₄:Yb³⁺/Er³⁺@PEG nanoparticles for multimodal<i>in vivo</i>tissue imaging

Uliana Kostiv, Volodymyr Lobaz, Jan Kučka et al. · Nanoscale · 2017 · 76 citations · Full text